XML 46 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
Note 15 - Stock-based Compensation and Other Benefit Plans (Tables)
9 Months Ended
Sep. 30, 2022
Notes Tables  
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

Three Months Ended September 30,

  

Nine Months Ended September 30,

 
  

2022

  

2021

  

2022

  

2021

 
  

(in thousands)

 

Stock-based compensation - equity awards

 $541  $327  $1,560  $767 

Stock-based compensation - liability awards

  (505)  (302)  740   1,331 

Total stock-based compensation

 $36  $25  $2,300  $2,098 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

Nine Months Ended September 30,

 
  

2022

  

2021

 

Weighted average exercise price - ($/share)

 $6.41  $3.14 

Expected life in years

  6.0   6.0 

Average expected volatility

  72%  75%

Risk-free interest rate

  1.98%  0.95%

Expected dividend yield

  2.30%   

Weighted average grant date fair value - ($/share)

 $2.84  $2.07 
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
  

Number of Shares Underlying Options

  

Weighted Average Exercise Price Per Share

  

Weighted Average Remaining Contractual Term

  

Aggregate Intrinsic Value

 
  

(in thousands)

      

(in years)

     

Outstanding at January 1, 2022

  359  $1.96         

Granted

  241   6.41         

Exercised

              

Unvested shares forfeited

              

Vested shares expired

              

Outstanding at September 30, 2022

  600  $3.75   8.59  $861 

Exercisable at September 30, 2022

  194  $1.68   7.90  $518 
  

Number of Shares Underlying Options

  

Weighted Average Exercise Price Per Share

  

Weighted Average Remaining Contractual Term

  

Aggregate Intrinsic Value

 
  

(in thousands)

      

(in years)

     

Outstanding at January 1, 2022

  615  $1.58         

Granted

              

Exercised

  (229)  1.12         

Unvested shares forfeited

              

Vested shares expired

              

Outstanding at September 30, 2022

  386  $1.86   1.21  $968 

Exercisable at September 30, 2022

  386  $1.86   1.21  $968 
Nonvested Restricted Stock Shares Activity [Table Text Block]
  

Restricted Stock

  

Weighted Average Grant Date Fair Value

 
  

(in thousands)

     

Non-vested shares outstanding at January 1, 2022

  741  $2.36 

Awards granted

  384   6.56 

Awards vested

  (334)  2.25 

Awards forfeited

  (32)  3.69 

Non-vested shares outstanding at September 30, 2022

  759  $4.48 
Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]
  

Number of Shares Underlying SARs

  

Weighted Average Exercise Price Per Share

  

Weight Average Remaining Contractual Term

  

Aggregate Intrinsic Value

 
  

(in thousands)

      

(in years)

  

(in thousands)

 

Outstanding at January 1, 2022

  362  $1.81         

Granted

              

Exercised

  (153)  1.71         

Unvested SARs forfeited

              

Vested SARs expired

              

Outstanding at September 30, 2022

  209  $1.88   1.11  $517 

Exercisable at September 30, 2022

  209  $1.88   1.11  $517